GGrantIndex
Sort

15,842 grants matching pancreatic cancer

MECHANISMS OF ANGIOGENESIS IN TRANSGENIC TUMORIGENESIS

$736,473
Children'S Hospital Boston · R01 · FY2003 · CA

Case-Control Study of Pancreas Cancer Etiologic Factors

$736,394
Harvey A Risch · Yale University · R01 · FY2006 · CA

Probing cytosolic nucleic acid sensing pathways in cancer

$736,310
Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA

Project 1: Systematic discovery of cell-intrinsic mechanisms of cancer drug resistance

$735,846
Scott R Manalis · Massachusetts Institute Of Technology · U54 · FY2020 · CA

COMBINING TROP2-DIRECTED CAR-NK CELLS WITH HIF2A INHIBITION FOR THE IMMUNOTHERAPHY OF PANCREATIC CANCER

$735,751
The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2025 · Defense Health Agency

Antibody Therapy of Cancer

$735,484
Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)

$735,208
Alison P Klein · Johns Hopkins University · R01 · FY2016 · CA

Dissecting the impact of tumor-intrinsic chromosomal instability on the cancer ecosystem

$735,170
Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis

$734,550
Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Case-Control Study of Pancreas Cancer Etiologic Factors

$733,890
Harvey A Risch · Yale University · R01 · FY2007 · CA

Bioinformatics

$733,665
Leping Li · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES

Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients

$733,228
Jada Gabrielle Hamilton · Sloan-Kettering Inst Can Research · U01 · FY2021 · CA

Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors

$733,009
Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer Cohort Con

$732,910
Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

LKB1 tumor suppressor and human cancer

$732,590
Diego H Castrillon · Ut Southwestern Medical Center · U01 · FY2013 · CA

Detection of Pre-Invasive Pancreatic Cysts Using Protein and Glycan Biomarkers

$732,422
Brian B Haab · Van Andel Research Institute · U01 · FY2010 · CA

Identification of synthetic lethal interactors in pancreatic cancer

$732,247
Channing J Der · Univ Of North Carolina Chapel Hill · U01 · FY2016 · CA

Role of Neurotrophins in the Development of the Mammalian Nervous System

$731,359
Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Case-Control Study of Pancreas Cancer Etiologic Factors

$731,357
Yale University · R01 · FY2004 · CA

Project 2-Identifying and exploiting metabolic vulnerabilities in PDAC

$731,128
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2021 · CA

Microbial- based targeting of major extracellular matrix components for improved therapy of pancreatic cancer

$730,400
Edwin Manuel · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA

Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer

$729,981
Anna M Wu · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA

METABOLIC INTERVENTIONS TO HALT PANCREATIC CANCER

$729,690
Cedars-Sinai Medical Center · · FY2024 · Defense Health Agency

Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy

$729,411
Lily Yang · Emory University · U01 · FY2016 · CA

Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer

$729,369
Syed Hussain · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA